Ahmed M. Almahrouky , Mohamed Rafik
Ahmed Faraghaly¹, Ahmed Elmarakby¹, Ahmed Gamal Eldin Fouad¹, Fatma Zeinhom² & Wesam El-Din Sultan³
Ahmad Gamal1, Haitham A. Eldmarany1, Ahmed Farghaly1, Ahmed Elmarakby1, Ayman Refaat2.
Ahmed Nawar1, Waleed Reda1, Ahmed Safwat1, Sahar Mansour2
Mohamed Saber MSc, Tarek Hegazy MD,MRCS
Hossam Elmahdy; Waleed Eldaly; Hussein Elwan; Baker Ghoneim
Ahmed H. Ali FRCS and Hany Rafik MD
Hany M S Mikhail MD, FRCS, Hany A. Balamoun MD, FRCS
Abd Elrahman Elmaraghy, Mahmoud Saad Farahat and Mohammed abdo MD
Mahmoud Saad1, Haitham Mostafa Elmaleh1and Safaa Refaat El-Sady2
Ahmed H. Ali,FRCS
1Amr Mohamed Salem, 2Mohamed Mohamed Mokhtar, 2Sahar Ahmed El Shafei, 3Omaima Gaber Yassine, 2Eman Farouk Safwat
Shehab Soliman , Ahmed F. Aborady
Mr. Ayman M. A. Osman1 MD, MRCS (Eng); Mr. Sameh A. Mikhail1 MD, FRCS (Eng), MRCS (Eng); Mr. Mohamed E. Alkashty1 M.Sc.; Prof. Mohamed H.A. Fahmy1 MD.
Sherif Essam Eldin Tawfik; Ahmed Farouk Abdelmohsen; Mohamed Abd El-Monem Abd El-salam Rizk
Marwan Yousry, Hossam El Mahdy, Walied Eldaly, Hussein Elwan
Wael Ghanem MD*, and Mohamed Eldebeiky MD, FRCS*, Ayman Albaghdady MD*
Wael Ghanem MD
Sameh Mikhail1, Shady Elghazaly Harb 1, Sherif M. Mokhtar 1, Mohamed ElNady 2
Amr Saleh El Bahaey and Haitham A.Eldmarany
Haitham A. Eldmarany1, Amr Saleh El Bahaey2
The Genetic Association of VKORC1 (-1639G<A) Polymorphism with Warfarin Dose Requirements among Egyptian Patients with Venous Thromboembolism
The aim of the study was to estimate the frequency of VKORC1 (-1639G<A) genotypes and to figure out the effect of “vitamin K epoxide reductase complex subunit 1” (VKORC1) gene polymorphism (-1639G<A) on “warfarin dose requirement” in a sample of Egyptian patients with “venous thromboembolism”.
Subjects & Methods: A case-control study was carried out in “the Medical Research Institute hospital, Alexandria University, Egypt”. Cases were patients with “venous thromboembolism”(VTE) admitted to the “Experimental and Clinical Surgery Department”. Controls were healthy volunteers without history of VTE. Coming to the hospital as patients’ relatives, within the same age range as cases. Both groups were included in the molecular study using PCR/RFLP technique for detection of (VKORC1) gene polymorphism (-1639G<A).
Results: The study comprised 37 cases and 47 controls. Twelve patients (32.4%) had GG genotype, 19 patients (51.4%) had AG genotype and 6patients (16.2%) had AA genotype. There was a significant variation in “warfarin maintenance dose “in patients with different genotypes of (VKORC1) at position -1639 suggesting that,(VKORC1) polymorphism has an essential role on the “warfarin maintenance dose” requirement. In addition, a statistical significant difference between VKORC1 (-1639G<A) genotypes and daily “warfarin maintenance dose”was found among cases. No significant difference was detected in Genotype and allele frequencies of VKORC1 (-1639G<A) polymorphism between both cases and controls. Conclusions: In the Egyptian patients with VTE, both VKORC1-1639G and VKORC1-1639A alleles were found with allelic frequency (58 % and 42 %) respectively. There was a significant variation in” warfarin maintenance dose” among patients with different genotypes of (VKORC1) at position -1639, and that (VKORC1) polymorphism has an important influence on the” warfarin dose requirements”.
Key words:”Venous Thromboembolism”, “warfarin maintenance dose”, VKORC1 (-1639G<A) genotypes, polymorphism.